FindTrial
Sign In

Intravitreal Anti-VEGF Combined with Dexamethasone for Central Retina Vein Occlusion with Macular Edema

Clinical trial of Intravitreal Anti-VEGF Combined with Dexamethasone for Central Retina Vein Occlusion with Macular Edema

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-INR-17011877
Enrollment
Unknown
Registered
2017-07-05
Start date
2017-07-01
Completion date
Unknown
Last updated
2017-07-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Central Retina Vein Occlusion

Interventions

1:Conbercept
2:Conbercept & Dex

Sponsors

Qingdao Eye Hospital, Shandong Eye Institute
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Diagnosed as ME secondary to CRVO; 2. BCVA=20/400 (=19ETDRS LETTERS); 3. Never intraocular injectionn,laser photocoagulation or introcular operation; 4. Signed the informed consent.

Exclusion criteria

Exclusion criteria: 1. Participated in other clinical trials within three months; 2. introcular operation within 6 months; 3. Accompanied by other retinal vascular diseases that may cause macular edema; 4. Severe refractive opacities affect laser treatment and efficacy; 5. Facts mayMay increase patient risk.

Design outcomes

Primary

MeasureTime frame
BCVA;CMT;—

Countries

China

Contacts

Public ContactWu Peipei

Qingdao Eye Hospital, Shandong Eye Institute

ree04@126.com+86 18561623801

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 6, 2026